Recent studies have highlighted epicatechin's potential as a promising therapy for Premature Ovarian Insufficiency (POI), as it can down-regulate increased oxidative stress levels via the PI3K/AKT/Nrf2 signaling pathway [81]. The gene discussed is AKT1; the disease is Premature ovarian insufficiency.